Literature DB >> 18686004

Cell therapy for tendinitis, experimental and clinical report.

L Lacitignola1, A Crovace, G Rossi, E Francioso.   

Abstract

To compare cultured bone marrow mesenchymal cells (cBMSC), bone marrow mononucleated cells (BMMNCs), and placebo to repair collagenase-induced tissue damage in an equine model of experimental tendonitis, 6 Standardbred horses with no signs of previous SDF tendon injury have been recruited. Three weeks after collagenase treatment an average of either 5.5 x 10(6) cBMSCs or 122.3 x 10(6) BMMNCs, saline solution (placebo) or fibrin glue were injected intralesionally in random order. Horses were stall rested for 21 weeks, and tendon ultrasound scans performed before and during this period. Horses were euthanized and tendons harvested for histology and immunohistochemistry. Data observed in this study showed effectiveness of cBMSC and BMMNC in regenerating tendon tissue after collagenase -induced tendonitis. Both cBMSC and BMMNC transplantation resulted in qualitatively similar regeneration of tendon extracellular matrix in terms of type I/III collagen ratio, fiber orientation, and COMP expression. After this favourable results, 20 horses were recruited referred for spontaneous lesions of the flexor tendons or the suspensory ligament. Horses were treated with autologous graft of BMMNCs.After treatment the. the exercise program allowed was 8 weeks stall rest, 4 weeks hand walking, 4 weeks trotting, 4 weeks of gradually raising of exercise level then horses were gone back to race. US characteristics of lesions started to improve at T3. CSA-l, FPS and TLS were better in all patients, with an appreciable filling of lesions indicated by a decreasing of CSA-l and increasing of TLS. When horses started the exercise program T8 tendon architecture improved, demonstrated by their longitudinal alignment and length. At T6, and persistently in later follow-up, no lameness was evident by clinical examination. At time of writing 12 patients (60%) were go back to races, while other 8 (40%) are under controlled exercise program. Re-injury rate was assessed at 25%. All the owners judged good to excellent the outcome in term of athletic success.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18686004     DOI: 10.1007/s11259-008-9085-3

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  18 in total

1.  Autologous mesenchymal stem cell-mediated repair of tendon.

Authors:  H A Awad; D L Butler; G P Boivin; F N Smith; P Malaviya; B Huibregtse; A I Caplan
Journal:  Tissue Eng       Date:  1999-06

Review 2.  Microenvironment and stem properties of bone marrow-derived mesenchymal cells.

Authors:  G Bianchi; A Muraglia; A Daga; G Corte; R Cancedda; R Quarto
Journal:  Wound Repair Regen       Date:  2001 Nov-Dec       Impact factor: 3.617

3.  Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment.

Authors:  R K W Smith; M Korda; G W Blunn; A E Goodship
Journal:  Equine Vet J       Date:  2003-01       Impact factor: 2.888

4.  Harnessing the stem cell for the treatment of tendon injuries: heralding a new dawn?

Authors:  R K W Smith; P M Webbon
Journal:  Br J Sports Med       Date:  2005-09       Impact factor: 13.800

5.  Modulation of proliferation and differentiation of human bone marrow stromal cells by fibroblast growth factor 2: potential implications for tissue engineering of tendons and ligaments.

Authors:  Stefan Hankemeier; Michaela Keus; Johannes Zeichen; Michael Jagodzinski; Tanja Barkhausen; Ulrich Bosch; Christian Krettek; Martijn Van Griensven
Journal:  Tissue Eng       Date:  2005 Jan-Feb

Review 6.  Tendon injury and tendinopathy: healing and repair.

Authors:  Pankaj Sharma; Nicola Maffulli
Journal:  J Bone Joint Surg Am       Date:  2005-01       Impact factor: 5.284

7.  Vascular patches tissue-engineered with autologous bone marrow-derived cells and decellularized tissue matrices.

Authors:  Seung-Woo Cho; Hee Jung Park; Ju Hee Ryu; Soo Hyun Kim; Young Ha Kim; Cha Yong Choi; Min-Jae Lee; Jong-Sung Kim; In-Sung Jang; Dong-Ik Kim; Byung-Soo Kim
Journal:  Biomaterials       Date:  2005-05       Impact factor: 12.479

Review 8.  Cell therapy for bone disease: a review of current status.

Authors:  Ranieri Cancedda; Giordano Bianchi; Anna Derubeis; Rodolfo Quarto
Journal:  Stem Cells       Date:  2003       Impact factor: 6.277

9.  Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation.

Authors:  Hung-Fat Tse; Yok-Lam Kwong; John K F Chan; Gladys Lo; Chi-Lai Ho; Chu-Pak Lau
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

10.  Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair.

Authors:  R G Young; D L Butler; W Weber; A I Caplan; S L Gordon; D J Fink
Journal:  J Orthop Res       Date:  1998-07       Impact factor: 3.494

View more
  16 in total

Review 1.  Biology and mechano-response of tendon cells: Progress overview and perspectives.

Authors:  Hui B Sun; Christoph Schaniel; Daniel J Leong; James H-C Wang
Journal:  J Orthop Res       Date:  2015-04-28       Impact factor: 3.494

2.  Characterization of adipose-derived equine and canine mesenchymal stem cells after incubation in agarose-hydrogel.

Authors:  Christina Schwarz; Uta Leicht; Inga Drosse; Veronika Ulrich; Volker Luibl; Matthias Schieker; Michael Röcken
Journal:  Vet Res Commun       Date:  2011-07-15       Impact factor: 2.459

3.  Semitendinosus myopathy and treatment with adipose-derived stem cells in working German shepherd police dogs.

Authors:  Melissa A Gibson; S Gary Brown; Nancy O Brown
Journal:  Can Vet J       Date:  2017-03       Impact factor: 1.008

4.  Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses.

Authors:  Paola Torricelli; Milena Fini; Giuseppe Filardo; Matilde Tschon; Mario Pischedda; Alessandra Pacorini; Elizaveta Kon; Roberto Giardino
Journal:  Int Orthop       Date:  2011-03-11       Impact factor: 3.075

Review 5.  Tendon regeneration in human and equine athletes: Ubi Sumus-Quo Vadimus (where are we and where are we going to)?

Authors:  Jan H Spaas; Deborah J Guest; Gerlinde R Van de Walle
Journal:  Sports Med       Date:  2012-10-01       Impact factor: 11.136

6.  The role of microvesicles derived from mesenchymal stem cells in tissue regeneration; a dream for tendon repair?

Authors:  Ciro Tetta; Anna Lange Consiglio; Stefania Bruno; Emanuele Tetta; Emanuele Gatti; Miryana Dobreva; Fausto Cremonesi; Giovanni Camussi
Journal:  Muscles Ligaments Tendons J       Date:  2012-10-16

7.  Stem cells and tendinopathy: state of the art from the basic science to clinic application.

Authors:  Laura Ruzzini; Umile Giuseppe Longo; Giacomo Rizzello; Vincenzo Denaro
Journal:  Muscles Ligaments Tendons J       Date:  2012-10-16

Review 8.  Mesenchymal Stem Cell-Derived Extracellular Vesicles for the Promotion of Tendon Repair - an Update of Literature.

Authors:  Pauline Po Yee Lui
Journal:  Stem Cell Rev Rep       Date:  2021-04       Impact factor: 5.739

9.  Fetal derived embryonic-like stem cells improve healing in a large animal flexor tendonitis model.

Authors:  Ashlee E Watts; Amy E Yeager; Oleg V Kopyov; Alan J Nixon
Journal:  Stem Cell Res Ther       Date:  2011-01-27       Impact factor: 6.832

Review 10.  Tendon regeneration and repair with stem cells.

Authors:  S MacLean; W S Khan; A A Malik; M Snow; S Anand
Journal:  Stem Cells Int       Date:  2011-10-27       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.